Cincinnati has become a nurturing place for bright ideas in biotechnology, and 2020 could bring big advancements.
The Cincinnati USA Regional Chamber of Commerce estimates the industry contributes more than $3 billion to the area economy. Nearly 800 locations employ more than 13,000 workers who are making average salaries of about $100,000 a year.
In alphabetical order, here are eight Cincinnati biotechs aiming for milestones in 2020.
The Covington company is testing its first-in-class treatment that attacks cancer cells without harming healthy tissue. In 2019, the company completed the first phase of U.S.
Food and Drug Administration testing in adults and started Phase 1 trials in children. Bexion aims to launch the next phase of trials for gastrointestinal and brain tumors in adults and children.